Inhibition of protein translational machinery in triple-negative breast cancer as a promising therapeutic strategy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibition of protein translational machinery in triple-negative breast cancer as a promising therapeutic strategy

Published:2024-05 Issue:5 Volume:5 Page:101552
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Dheeraj Arpit,Garcia Marques Fernando Jose,Tailor Dhanir,Bermudez Abel,Resendez Angel,Pandrala Mallesh,Grau Benedikt,Kumar Praveen,Haley Carrsyn B.,Honkala Alexander,Kujur Praveen,Jeffrey Stefanie S.,Pitteri Sharon,Malhotra Sanjay V.^ORCID

Funder

Knight Cancer Institute, Oregon Health and Science University

Oregon Institute of Occupational Health Sciences, Oregon Health and Science University

Publisher

Elsevier BV

Reference53 articles.

1. Breast cancer;Harbeck;Nat. Rev. Dis. Prim.,2019

2. Breast Cancer Treatment: A Review;Waks;JAMA,2019

3. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease;Bianchini;Nat. Rev. Clin. Oncol.,2016

4. RNA-binding proteins and cancer metastasis;Wang;Semin. Cancer Biol.,2022

5. Cold shock proteins: from cellular mechanisms to pathophysiology and disease;Lindquist;Cell Commun. Signal.,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP